Eye on FDA

JANUARY 5, 2022

But before heading into 2022, it is perhaps time to take stock of AdComms and what they did or did not do during 2021. First and foremost is that as noted earlier this year (See August 5, 2021 FDA Adcomms – Is FDA Getting Less Advice? ), there were fewer 2021 meetings held to consider new drug applications than in years gone by.

FDA 76

FDA Clinical Pharmacology Vaccine Production 76

Drug Channels

SEPTEMBER 24, 2023

billion (+22.3%) higher than its 2021 counterpart. I couldn’t wait to share the news, hence this special Sunday post. For 2022, discounted purchases under the 340B program reached a record $53.7 billion —an astonishing $9.8 The difference between list prices and discounted 340B purchases also grew, to $52.3 billion (+$2.6

Pharmacy 96

Pharmacy Hospitals Drugs 96

SCIENMAG: Medicine & Health

JUNE 15, 2023

Credit: The Lancet Journal The Lancet Haematology Article Title Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 Article Publication Date 15-Jun-2023

Disease 84

Disease 84

Drug Discovery Today

DECEMBER 21, 2021

Lab Innovations, the UK’s largest trade exhibition for the laboratory industry, returned to the NEC, Birmingham, on November 3 and 4, 2021 and brought the laboratory community together for the first time after almost two years apart.

Laboratories 113

Laboratories 113

Drug Channels

MAY 10, 2022

When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. What’s more, average net drug prices have declined for the past five years—though a few companies had net price gains or slower declines in 2021. healthcare expenditures.

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

JUNE 6, 2022

The retail pharmacy shakeout affected 2021 pharmacist employment. Time for an update to the Drug Channels Institute (DCI) annual analysis of pharmacist salaries and employment. We found that retail pharmacies and drugstores employed fewer pharmacists, while hospitals and outpatient centers continued to add positions.

Pharmacy 98

Pharmacy Hospitals Marketing Drugs 98

Drug Channels

JULY 28, 2022

When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. What’s more, average net drug prices have declined for the past five years—though a few companies had net price gains or slower declines in 2021. healthcare expenditures.

Pharmaceuticals 98

Pharmaceuticals Drugs 98

The Pharma Data

AUGUST 3, 2021

Revenue in the second quarter of 2021 increased 23 percent, driven by volume growth of 22 percent. – Revenue from all key products grew in the quarter and 2021 year-to-date. . – Revenue from all key products grew in the quarter and 2021 year-to-date. – 2021 EPS guidance updated to be in the range of $6.73

Production 52

Production Marketing Research Government 52

Drug Channels

DECEMBER 16, 2022

Fortunately, my 2022 FOIA efforts (described below) extracted purchases by 340B covered entity type for 2015 through 2021. Here’s a summer surprise for fans of the 340B Drug Pricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! The data tell a familiar story.

Hospitals 97

Hospitals Drugs Pharmacy 97

Drug Channels

SEPTEMBER 14, 2021

On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. We are providing you with the opportunity to preorder this thoroughly updated and revised 2021-22 edition at special discounted prices. pharmaceutical distribution industry. to 1:30 p.m.

Pharmaceuticals 94

Pharmaceuticals Marketing Drugs 94

Drug Channels

MAY 3, 2022

In Drug Channels Institute’s list of the top 15 pharmacies of 2021 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. You will see that PBMs and insurers retained their dominance over specialty dispensing.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

JULY 27, 2022

In Drug Channels Institute’s list of the top 15 pharmacies of 2021 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. You will see that PBMs and insurers retained their dominance over specialty dispensing.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs 98

SCIENMAG: Medicine & Health

AUGUST 7, 2023

Social media helped contribute to the UPND’s impressive victory in the 2021 Zambia elections, new analysis shows. The party’s online messaging resonated more with users compared to their rivals, helping to portray Hakainde Hichilema as an electorally viable alternative to President Edgar Lungu from the PF.

68

68

The Pharma Data

JULY 8, 2021

Nasdaq:BIIB) today announced it will report second quarter 2021 financial results Thursday, July 22, 2021, before the financial markets open. Biogen Inc. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m.

Biosimilars 52

Biosimilars Disease Therapies Treatment 52

Drug Channels

AUGUST 15, 2022

Here’s a summer surprise for fans of the 340B Drug Pricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! For 2021, discounted purchases under the 340B program reached a record $43.9 The data tell a familiar story. billion —an astonishing $5.9

Hospitals 98

Hospitals Drugs Pharmacy 98

Drug Channels

JULY 25, 2022

For 2021, we estimate that the three biggest PBMs accounted for 80% of total equivalent prescription claims. The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below.

Pharmacy 98

Pharmacy Marketing Drugs 98

Eye on FDA

JANUARY 12, 2022

During nearly all of 2021, FDA has been under the direction of an acting commissioner. COVID – 144 announcements were COVID-related in 2021, compared to 274 such announcements during 2020; Approvals – there were 77 announcements related to approvals this year, 22 of which were COVID-related announcements.

FDA 73

FDA Vaccine Production Therapies 73

The Pharma Data

JULY 29, 2021

Second-Quarter 2021 Revenues of $19.0 Billion The 10% Operational Growth Excluding BNT162b2(1) in Second-Quarter 2021 Builds on the 6% Operational Growth Delivered by the Comparable Business in Second-Quarter 2020 Second-Quarter 2021 Reported Diluted EPS(2) of $0.98, Adjusted Diluted EPS(3) of $1.07

Biosimilars 52

Biosimilars Vaccine International Production 52

The Pharma Data

APRIL 9, 2021

today announced it will report first quarter 2021 financial results Thursday, April 22, 2021, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. To access the live webcast, please go to the investors section of Biogen’s website at [link].

Biosimilars 52

Biosimilars Disease Therapies Treatment 52

Drug Channels

APRIL 5, 2022

For 2021, we estimate that the three biggest PBMs accounted for 80% of total equivalent prescription claims. The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 8, 2022

prescription dispensing revenues for calendar year 2021. prescription dispensing revenues reached a record $501 billion in 2021. The exhibit below—one of 216 in our new report—provides a first look at the 15 largest organizations, ranked by total U.S.

Pharmacy 98

Pharmacy Marketing Drugs 98

The Pharma Data

MARCH 11, 2021

Bristol Myers Squibb (NYSE:BMY) will announce results for the first quarter of 2021 on Thursday, April 29, 2021. ET on April 29, 2021, company executives will review financial results and address inquiries from investors and analysts. ET on May 13, 2021. During a conference call at 9 a.m. Source link:[link].

International 52

International 52

The Pharma Data

MAY 14, 2021

Product Name: My Cellulite Solution – Updated April 2021. Click here to get My Cellulite Solution – Updated April 2021 at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Production 52

Production Vaccine 52

Drug Discovery Today

JANUARY 23, 2021

The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021

Production 113

Production 113

The Pharma Data

AUGUST 1, 2021

per share dividend for the third quarter of 2021. The dividend will be paid on September 8, 2021, to all stockholders of record as of the close of business on August 17, 2021. Amgen today announced that its Board of Directors declared a $1.76

Disease 52

Disease 52

Eye on FDA

JULY 19, 2021

But here is what we see looking at the first 6 months 2021, and comparing it to mid-years past. It has been a regular feature of the blog to give a read on what FDA has been talking about, at least through the form of press releases. Of the 153, only 33 of them were translated into Spanish.

FDA 93

FDA Vaccine Treatment Drugs 93

The Pharma Data

JUNE 30, 2021

he board of directors of Eli Lilly and Company (NYSE: LLY) (the “Board”) has declared a dividend for the third quarter of 2021 of $0.85 The dividend is payable on September 10, 2021 to shareholders of record at the close of business on August 13, 2021. per share on outstanding common stock.

Disease 52

Disease 52

Drug Patent Watch

JUNE 8, 2021

FYCOMPA (perampanel) Eisai inc Patent: 6,949,571 Expiration: Jun 8, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or….

Drugs 74

Drugs Pharmaceuticals 74

The Pharma Data

JANUARY 4, 2021

5, 2021 07:00 UTC. February 12, 2021. March 25, 2021. 2021 First Quarter Financial Update. April 21, 2021. 2021 Second Quarter Financial Update. July 21, 2021.

Clinical Trials 52

Clinical Trials Trials Treatment Disease 52

The Pharma Data

MARCH 4, 2021

per share dividend for the second quarter of 2021. The dividend will be paid on June 8, 2021, to all stockholders of record as of the close of business on May 17, 2021. Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76 About Amgen .

Disease 52

Disease 52

The Pharma Data

JULY 29, 2021

econd Quarter 2021 Product Sales Increased 21% Year-Over-Year Primarily Driven by Veklury. Nasdaq: GILD) announced today its results of operations for the second quarter 2021. “We Second Quarter 2021 Financial Results. Total second quarter 2021 revenue of $6.2 As of June 30, 2021, Gilead had $7.4

Science 52

Science Production Treatment FDA 52

Drug Channels

DECEMBER 7, 2021

For 2021, employers backed away slightly from high-deductible health plans. Please join me for my upcoming live video webinar, Drug Channels Outlook 2022 , on December 17, 2021, from 12:00 p.m. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. to 1:30 p.m. Will you be there, too? d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs 98

The Pharma Data

DECEMBER 1, 2020

02, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today released its 2021 financial calendar: March 18, 2021: Publication of 2020 financial statements. MARSEILLE, France, Dec. . .

Cell Biology 52

Cell Biology Clinical Trials Licensing Licensing 52

The Pharma Data

MARCH 5, 2021

Biogen (Nasdaq: BIIB) today announced it will host webcasts of its pre-recorded presentations and live discussions related to its Alzheimer’s disease investigational therapy, aducanumab, at the upcoming AD/PDTM 2021 Virtual Conference. AD/PD Webcast Schedule Details: Wednesday, March 10, 2021, 6:45 a.m.

Licensing 52

Licensing Licensing Biosimilars Disease 52

Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. The notable new material in this 2021-22 edition includes three new sections: Section 4.2.5. Copyright © 2006-2021 Pembroke Consulting, Inc. Section 4.4.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Patent Watch

MAY 23, 2021

ZOMIG (zolmitriptan) Astrazeneca Patent: 7,220,767 Expiration: May 28, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit….

Drugs 69

Drugs Pharmaceuticals 69

Drug Channels

JULY 26, 2022

We estimate that the gross-to-net bubble reached $204 billion for patent-protected brand-name drugs in 2021. Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions.

Pharmaceuticals 94

Pharmaceuticals Drugs 94